Continued hCG surveillance following chemotherapy for gestational trophoblastic neoplasia: When is enough enough?

Kevin M Elias1, Ross S Berkowitz1, Neil S Horowitz1

  • 1New England Trophoblastic Disease Center, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02115 USA.

Gynecologic Oncology
|October 12, 2019
PubMed
Abstract

No abstract available in PubMed .

Related Concept Videos